ArticlePlants (Basel, Switzerland)2023
Biocontrol Potential of an Endophytic
Article in Plants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 7 citations in OpenAlex.
- Induction of Defense Responses and Partial Control of Powdery Mildew and Gray Mold inPlants (Basel, Switzerland) · 2026Article
- Promoting L-theanine accumulation in Camellia sinensis through irrigation with Pseudomonas knackmussii.Plant cell reports · 2025Article
- Native Bacteria Are Effective Biocontrol Agents at a Wide Range of Temperatures ofPlants (Basel, Switzerland) · 2025Article
- Characterization and bioefficacy of grapevine bacterial endophytes againstFrontiers in microbiology · 2024Article
- Grapevines escaping trunk diseases in New Zealand vineyards have a distinct microbiome structure.Frontiers in microbiology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 3 countries.
Funding
Abstract
Grapevine trunk diseases (GTDs) impact the sustainability of vineyards worldwide and management options are currently limited. Biological control agents (BCAs) may offer a viable alternative for disease control. With an aim to develop an effective biocontrol strategy against the GTD pathogen
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.